Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 2 1Phase 1/2 1Phase 1 1

Status

Recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Carcinoma, Non-Small-Cell Lung 53Neoplasms 49Neoplasm Metastasis 44Colorectal Neoplasms 44Leukemia, Myeloid, Acute 42Breast Neoplasms 40Prostatic Neoplasms 36Multiple Myeloma 31Ovarian Neoplasms 29Recurrence 26Melanoma 24Lymphoma, Non-Hodgkin 24Squamous Cell Carcinoma of Head and Neck 23Precursor Cell Lymphoblastic Leukemia-Lymphoma 23Pancreatic Neoplasms 23Triple Negative Breast Neoplasms 21Myelodysplastic Syndromes 21Endometrial Neoplasms 20Carcinoma, Renal Cell 18Stomach Neoplasms 17Small Cell Lung Carcinoma 17Lung Neoplasms 17Advanced Solid Tumors 17Carcinoma, Hepatocellular 15Brain Neoplasms 15Sarcoma 14Glioblastoma 14Esophageal Neoplasms 12Urinary Bladder Neoplasms 11Solid Tumors 11

Interventions

pomalidomide 1Vincristine 1Rituximab 1Prednisone 1Etoposide 1Doxorubicin 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Plasmablastic Lymphoma × 30 days × Clear all
NCT05389423 2026-06-01

Pomalidomide and Dose-Adjusted EPOCH +/- Rituximab for HIV-Associated Lymphomas

National Institutes of Health Clinical Center (CC)

Phase 1 Recruiting
25 enrolled
Lymphoid

Plasmablastic Lymphoma, Burkitt Lymphoma, Lymphoma, Non-Hodgkin, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Epstein-Barr Virus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡